Zimmer Biomet increases 2026 share buyback plan to $1.0 billion

Filed May 12, 2026 · Period ending May 12, 2026 · ~1 min read

Key Changes

• high

  Company will repurchase up to $1.0 billion of shares during fiscal 2026, an increase from previously disclosed capital allocation plans. The buyback operates under a $1.5 billion authorization approved by the Board in February 2026.

  Item 8.01 view on EDGAR →
• high

  The increased repurchase commitment signals management confidence in the business and represents a more aggressive return of capital to shareholders than originally planned for the year.

  Item 8.01 view on EDGAR →
• low

  Press release furnished under Item 7.01 is not deemed filed under the Exchange Act and will not be incorporated by reference into other SEC filings unless expressly stated.

  Item 7.01 verify on EDGAR →